Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QuinTron is a private U.S. medical device and diagnostics company focused on breath-testing systems for gastrointestinal disorders. Founded in 1961, the company develops and manufactures breath analyzers, sample collection systems, and at-home breath test kits used by hospitals, clinics, and laboratories. Its products are designed to measure trace gases such as hydrogen, methane, and carbon dioxide to support evaluation of conditions including carbohydrate malabsorption, small intestinal bacterial overgrowth, and intestinal methanogen overgrowth. QuinTron also serves adjacent research and specialty markets, including pharmaceutical research, veterinary science, and other breath-analysis applications. The company appears to operate as a commercial-stage manufacturer rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on QuinTron Instrument Company.